Although serum endocan was found to lack a correlation with FLI and HSI, ROC analysis revealed a prediction of NAFLD at 122.583 pg/mL for the first time in metabolic syndrome. This evidence concerns the gene ESM1 and metabolic dysfunction-associated steatotic liver disease.